COVID-19 Update: Research
Showing of 87 results
Research and Innovation Fuel UH's Response to COVID-19
We are among the first hospitals to conduct a clinical trial on the drug remdesivir, and are “thinking outside the box” in many other ways - UH Clinical Update | May 2020
UH Continues to Battle COVID-19 Through Research and Clinical Trials
Clinical Trials Awareness Week 2020
Marathon Run to Support Pioneering Genomic Research into Signet Ring Colon Cancer
Joseph Willis, MD, a member of the Signet Ring Colon Cancer Research Group at UH Seidman Cancer Center will be running the Rite Aid Cleveland Marathon on Saturday, May 16th to raise funds for this innovative program. Support the Signet Ring...
Athersys and UH announce activation of first clinical site for MACOVIA study, a pivotal Phase 2/3 study evaluating Multistem® cell therapy for COVID-19 induced ARDS
UH Cleveland Medical Center, a nationally ranked hospital, is ready to start screening patients - News Release
Harrington Discovery Institute Issues Transatlantic Call for Proposals to Treat Coronavirus and its Clinical Impact
Philanthropic drug development program seeks to accelerate treatments into human clinical trials - UH News Release
UH to Launch Clinical Trial in the Fight to Protect Clinicians Against COVID-19
Investigational drug, ARMS-I, manufactured by ARMS Pharmaceutical may prevent airborne transmission of coronavirus - UH News Release